PHARMACEUTICAL COMPOSITIONS WITH METFORMIN AND GLIBENCLAMIDE FOR THE TREATMENT OF DIABETES MELLITUS TYPE II

摘要

Orally administrable pharmaceutical compositions in the form of tablets, comprising glibenclamide and metformin, or pharmaceutically acceptable salts thereof, as active ingredients, maintained separate from one another within the same composition, are described for the treatment of type-II diabetes mellitus.